• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ketamine-induced cholangiopathy in ARDS patients.

作者信息

de Tymowski Christian, Dépret François, Dudoignon Emmanuel, Legrand Matthieu, Mallet Vincent

机构信息

Department of Anesthesiology and Critical Care and Burn Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier St-Louis-Lariboisière, Paris, France.

University de Paris, Paris, France.

出版信息

Intensive Care Med. 2021 Oct;47(10):1173-1174. doi: 10.1007/s00134-021-06482-3. Epub 2021 Jul 27.

DOI:10.1007/s00134-021-06482-3
PMID:34313797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8315088/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8315088/564bad7be60d/134_2021_6482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8315088/564bad7be60d/134_2021_6482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5171/8315088/564bad7be60d/134_2021_6482_Fig1_HTML.jpg

相似文献

1
Ketamine-induced cholangiopathy in ARDS patients.急性呼吸窘迫综合征患者中的氯胺酮诱发的胆管病
Intensive Care Med. 2021 Oct;47(10):1173-1174. doi: 10.1007/s00134-021-06482-3. Epub 2021 Jul 27.
2
Recreational ketamine-induced cholangiopathy and ulcerative cystitis.娱乐性氯胺酮诱导的胆管病和溃疡性膀胱炎。
Am J Emerg Med. 2021 Jul;45:682.e7-682.e9. doi: 10.1016/j.ajem.2020.12.025. Epub 2020 Dec 15.
3
Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered".回复：“COVID-19患者的进行性胆管病：除氯胺酮诱导的胆管病外，应考虑其他可能的诊断”。
J Hepatol. 2021 Oct;75(4):990-992. doi: 10.1016/j.jhep.2021.06.024. Epub 2021 Jun 24.
4
Postoperative acute respiratory distress syndrome in patients with previous exposure to bleomycin.既往接触博来霉素患者的术后急性呼吸窘迫综合征。
Mayo Clin Proc. 2014 Feb;89(2):181-9. doi: 10.1016/j.mayocp.2013.11.007.
5
Predictors of acute respiratory distress syndrome in patients with paraquat intoxication.百草枯中毒患者急性呼吸窘迫综合征的预测因素。
PLoS One. 2013 Dec 11;8(12):e82695. doi: 10.1371/journal.pone.0082695. eCollection 2013.
6
Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered.新型冠状病毒肺炎患者的进行性胆管病：除氯胺酮诱发的胆管病外，还应考虑其他可能的诊断。
J Hepatol. 2021 Oct;75(4):989-990. doi: 10.1016/j.jhep.2021.02.036. Epub 2021 Mar 19.
7
Long non-coding RNA SNHG5 suppresses the development of acute respiratory distress syndrome by targeting miR-205/COMMD1 axis.长链非编码 RNA SNHG5 通过靶向 miR-205/COMMD1 轴抑制急性呼吸窘迫综合征的发展。
Mol Cell Biochem. 2021 Feb;476(2):1063-1074. doi: 10.1007/s11010-020-03972-8. Epub 2020 Nov 10.
8
Ketamine-induced cholangiopathy.氯胺酮诱发的胆管病。
Hong Kong Med J. 2014 Feb;20(1):78.e1-e2. doi: 10.12809/hkmj133796.
9
Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischaemia-reperfusion injury.C-X-C基序趋化因子受体4的药理学调节影响肺缺血再灌注损伤后急性呼吸窘迫综合征的发生发展。
Clin Exp Pharmacol Physiol. 2018 Jan;45(1):16-26. doi: 10.1111/1440-1681.12845. Epub 2017 Sep 20.
10
Ketamine-induced cholangiopathy: a case report.氯胺酮诱发的胆管病：一例报告。
Am J Gastroenterol. 2011 May;106(5):1004-5. doi: 10.1038/ajg.2010.485.

引用本文的文献

1
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case series.重症发热感染相关癫痫综合征（FIRES）患者的继发性硬化性胆管炎：病例系列
Front Neurol. 2025 Apr 24;16:1557377. doi: 10.3389/fneur.2025.1557377. eCollection 2025.
2
Presence of cholestasis and its impact on survival in SARS-CoV-2 associated acute respiratory distress syndrome.胆汁淤积症的存在及其对 SARS-CoV-2 相关急性呼吸窘迫综合征患者生存的影响。
Sci Rep. 2024 Oct 8;14(1):23377. doi: 10.1038/s41598-024-73948-x.
3
COVID-19-Related Cholangiopathy: Histological Findings.

本文引用的文献

1
Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients.继发性硬化性胆管炎：危重症COVID-19患者中一种新出现的并发症。
Intensive Care Med. 2021 Sep;47(9):1037-1040. doi: 10.1007/s00134-021-06445-8. Epub 2021 Jun 29.
2
Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.继发硬化性胆管炎是重症 COVID-19 患者持续性黄疸的病因。
Liver Int. 2021 Oct;41(10):2404-2417. doi: 10.1111/liv.14971. Epub 2021 Jul 4.
3
Analgesia and sedation in patients with ARDS.
新型冠状病毒肺炎相关胆管病：组织学表现
Diagnostics (Basel). 2024 Aug 19;14(16):1804. doi: 10.3390/diagnostics14161804.
4
"Dosis sola facit venenum"-Evidence for causality in the association between ketamine and cholestatic liver injury.“唯剂量决定毒性”——氯胺酮与胆汁淤积性肝损伤之间关联的因果关系证据
Hepatol Int. 2024 Jun;18(3):1056-1057. doi: 10.1007/s12072-024-10646-w. Epub 2024 Mar 13.
5
Role of intravenous ketamine in the pathogenesis of secondary sclerosing cholangitis in critically ill patients: perpetrator or innocent bystander? Answers provided by forensic toxicology.静脉注射氯胺酮在危重症患者继发性硬化性胆管炎发病机制中的作用：罪魁祸首还是无辜旁观者？法医毒理学给出的答案
Intensive Care Med. 2023 Dec;49(12):1549-1551. doi: 10.1007/s00134-023-07257-8. Epub 2023 Nov 9.
6
Post-COVID-19 cholangiopathy: Systematic review.新冠病毒感染后胆管病：系统评价
World J Methodol. 2023 Sep 20;13(4):296-322. doi: 10.5662/wjm.v13.i4.296.
7
Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?新型冠状病毒肺炎后的继发性硬化性胆管炎：危重症患者在胆汁缺血情况下使用重症监护病房氯胺酮还是病毒特异性胆管嗜性及损伤？
Hepat Med. 2023 Aug 1;15:93-112. doi: 10.2147/HMER.S384220. eCollection 2023.
8
Efficacy and safety of ketamine for neonatal refractory status epilepticus: case report and systematic review.氯胺酮治疗新生儿难治性癫痫持续状态的疗效和安全性：病例报告及系统评价
Front Pediatr. 2023 Jun 2;11:1189478. doi: 10.3389/fped.2023.1189478. eCollection 2023.
9
Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19.COVID-19 患者长期使用氯胺酮后肝胆汁淤积生物标志物的特征。
BMC Anesthesiol. 2023 Feb 7;23(1):44. doi: 10.1186/s12871-023-02006-2.
10
Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review.新冠肺炎患者 ICU 住院期间的急性肝损伤：叙事性综述。
World J Gastroenterol. 2022 Dec 21;28(47):6662-6688. doi: 10.3748/wjg.v28.i47.6662.
急性呼吸窘迫综合征患者的镇痛与镇静。
Intensive Care Med. 2020 Dec;46(12):2342-2356. doi: 10.1007/s00134-020-06307-9. Epub 2020 Nov 10.